Interview with Troy Guthrie, Managing Director, Stiefel Laboratories Pty Limited
What impact will the recent PBS reforms have on Stiefel’s operations in Australia? Stiefel has no products on…
Stiefel Laboratories Pty Limited
Last updated: 13.02.2014
Address: ABN 47 100 162 481. Melbourne, VIC. ,Australia
Tel: 1800 033 109
Web: http://www.stiefel.com/home.html
Company description
Stiefel Laboratories is a specialized pharmaceutical company with a singular, steadfast focus on the advancement of dermatology and skin care around the world.
Stiefel Laboratories is renowned for its legacy of more than 160 years of ‘skin care firsts,’ endeavoring to provide the highest quality, most effective prescription and over the counter skin care products available in more than 100 countries.
One of Stiefel Laboratories’ primary missions is to make our products available in as many countries as possible, as soon as possible. Stiefel Laboratories has a sense of urgency to improve the quality of life for millions of people around the world.
Products and services
Dermatology
Interviews
Related
Australia / Opportunities for the Life Science Industry post-COVID
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully…
Australia / Growing Clinical Trials Even in Pandemic’s Wake
In an exclusive new podcast, DIA Global Forum Australia/New Zealand Regional Editor Richard Day (University of…
Opinion / The Powerful Impact of Taking a Patient-Centric Approach in an Evolving Health Landscape
Janssen Australia & New Zealand’s Bruce Goodwin argues that greater adoption of patient-centric practices…
Interview with Mal Eutick, CEO, Phebra Australia
Can you start by giving our readers a brief overview of the company’s history here and your most notable…
Interview with Marisa Petersen, Managing Director, George Clinical, Australia
Would you begin by outlining the role & importance of George Clinical within the George Institute, highlighting…
Interview with Vlado Perkovich, Executive Director, The George Institute,…
Would you begin by giving an introduction to our international readers of the institute, highlighting recent…
Interview with John Chalmers, Senior Director, The George Institute
For those that are not familiar with your name, would you start by introducing yourself? After obtaining my PhD in…
Interview with Megan Fookes, Director, Rare Voices
Rare Voices Australia is a new organisation that has been established after the national rare diseases symposium in…
Australia: Where Value Beats Cost
In some ways the Australian medicines industry is going through the same restructuring and challenges as the…
Interview with Craig Moore, Director, Hahn Healthcare
Can you outline the significance of the current PBS to the industry and in particular the impact it has on service…
Interview with Radek Sali, CEO, SWISSE
Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After…
Interview with Albert Spanos, General Manager, Celgene Australia
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in…
